Form 4 holding
CMO
CytoDyn Inc.
- Security class
- Common Stock
- Shares / value
- 2,184,037
- Estimated value
- $1,638,028
- Report date
- 30 Nov 2022
- Price
- $0.7500
- Ownership
- Direct
Scott A. Kelly - CMO at CytoDyn Inc.
Issuer-level insider activity
- Role
- Cmo
- Issuer ticker
- CYDY on OTC
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by Scott A. Kelly since 14 Sep 2025
Reported holdings for Scott A. Kelly in CytoDyn Inc.
Form 4 holding
CMO
CytoDyn Inc.
- Security class
- Common Stock
- Shares / value
- 782,408
- Estimated value
- $586,806
- Report date
- 28 Nov 2022
- Price
- $0.7500
- Ownership
- By Spouse
Form 4 holding
CMO
CytoDyn Inc.
- Security class
- Non-qualified stock option (right to buy)
- Shares / value
- 2,315,439
- Estimated value
- Report date
- 28 Nov 2022
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Scott A. Kelly in CytoDyn Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.